```html

Postmenopausal Bleeding – What You Need to Know

What is Postmenopausal Bleeding?

Postmenopausal bleeding (PMB) is any vaginal bleeding that occurs after a woman has gone 12 consecutive months without a menstrual period, which defines menopause. While occasional spotting can be benign, any bleeding after menopause is considered abnormal and warrants evaluation because it can signal a range of conditions—from harmless hormonal fluctuations to potentially life‑threatening cancers.

Because the endometrium (the lining of the uterus) is normally thin and atrophic after menopause, even a small amount of blood can be a sign that the lining is being stimulated to grow or that tissue is being shed abnormally. Early detection and treatment are essential for the best outcomes.

Common Causes

More than one cause can be present at the same time. The most frequent etiologies, listed from most to least common, include:

• Endometrial atrophy – thinning of the uterine lining due to low estrogen levels.
• Endometrial hyperplasia – thickening of the lining, often from unopposed estrogen.
• Endometrial (uterine) cancer – the most serious cause; accounts for ~10% of PMB cases.
• Uterine polyps – benign overgrowths of endometrial tissue that can bleed.
• Cervical polyps or cancer – polyps are common, while cervical cancer is rarer but possible.
• Hormone therapy (HT) – especially unopposed estrogen or improper dosing of combined therapy.
• Vaginal atrophy (atrophic vaginitis) – dryness and irritation can cause minor bleeding.
• Medication side effects – anticoagulants, antiplatelet drugs, and selective serotonin reuptake inhibitors (SSRIs) can increase bleeding risk.
• Coagulopathies – inherited or acquired bleeding disorders, such as von Willebrand disease.
• Other gynecologic lesions – including submucosal fibroids, endometrial carcinoma in situ, or rare infections.

Associated Symptoms

PMB may occur alone or alongside other signs that can help pinpoint the underlying cause:

• Pelvic pain or pressure
• Foul‑smelling vaginal discharge
• Itching, burning, or dryness of the vulva
• Unexplained weight loss or loss of appetite (potential red flag for cancer)
• Sudden onset of heavy bleeding (more than a normal menstrual flow)
• Frequent urination or urinary urgency (if the uterus or bladder is compressed by a mass)
• Abdominal bloating or fullness

When to See a Doctor

Any postmenopausal bleeding should prompt a prompt medical evaluation. Seek care promptly if you notice:

• Any amount of vaginal blood after 12 months of amenorrhea
• Bleeding that is heavy, persistent for more than a few days, or recurs intermittently
• Bleeding accompanied by pelvic pain, unusual discharge, or foul odor
• Symptoms of anemia (fatigue, shortness of breath, dizziness)
• History of endometrial hyperplasia, uterine fibroids, or estrogen‑based hormone therapy

Diagnosis

Evaluation follows a stepwise approach that combines a detailed history, physical examination, and targeted investigations.

1. Medical History & Physical Exam

• Age at menopause, duration of bleeding, pattern (spotting vs. flow)
• Use of hormone therapy, contraceptives, anticoagulants, or herbal supplements
• Personal or family history of gynecologic cancers
• Pelvic exam to assess the vulva, vagina, cervix, and uterus for visible lesions or atrophy

2. Laboratory Tests

• Transvaginal ultrasound (TVUS) – first‑line imaging; measures endometrial thickness. A thickness <4 mm is generally reassuring, while >5 mm warrants further work‑up.
• Endometrial biopsy – office‑based pipelle sampling of the lining; definitive for hyperplasia or cancer.
• Pap smear / HPV testing – to rule out cervical pathology.
• Complete blood count (CBC) – assesses anemia.
• Coagulation profile if anticoagulant use or bleeding disorder is suspected.

3. Advanced Imaging & Procedures

• Hysteroscopy – direct visualization of the uterine cavity; allows targeted biopsy or removal of polyps/fibroids.
• Saline infusion sonohysterography (SIS) – enhances ultrasound detection of intracavitary lesions.
• Magnetic resonance imaging (MRI) – used when cancer invasion or complex pelvic masses are suspected.

Treatment Options

Treatment depends on the identified cause, the patient's overall health, and personal preferences. Options range from simple observation to surgery.

1. Hormonal & Medical Management

• Local estrogen therapy (e.g., vaginal tablets, creams) – for atrophic vaginitis; improves mucosal integrity and reduces bleeding.
• Progestin therapy – cyclic or continuous oral progestins can counteract unopposed estrogen and thin the endometrium.
• Low‑dose combined hormone therapy – for women already on HT who develop bleeding; dose adjustment often resolves symptoms.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – may reduce bleeding associated with polyps or mild inflammation.

2. Procedural & Surgical Options

• Polypectomy – removal of uterine or cervical polyps via hysteroscopy; often curative.
• Endometrial ablation – destroys the lining; suitable for benign hyperplasia without atypia.
• Hysterectomy – definitive treatment for cancer, severe hyperplasia, or refractory bleeding; can be total (removing uterus and cervix) or subtotal.
• Laparoscopic or robotic myomectomy – removal of submucosal fibroids when fertility preservation is desired.
• Radiation/chemotherapy – reserved for advanced endometrial cancer.

3. Supportive & Home Care

• Maintain adequate iron intake (dietary iron or supplements) if anemia is present.
• Use gentle, unscented soaps and moisturizers to reduce vaginal irritation.
• Track bleeding episodes in a diary to help the clinician monitor response to therapy.

Prevention Tips

While menopause itself cannot be prevented, several strategies can lower the risk of PMB:

• Use hormone therapy under a physician’s guidance; avoid unopposed estrogen.
• Maintain a healthy weight – excess adipose tissue can produce estrogen.
• Regular pelvic examinations and Pap smears as recommended (typically every 3‑5 years after age 65).
• Screen for and treat endometrial hyperplasia early, especially if you have risk factors such as polycystic ovary syndrome (PCOS) or a history of tamoxifen use.
• Limit alcohol and quit smoking; both are linked to higher cancer risk.
• Stay active – regular exercise helps regulate hormonal balance.
• Discuss any use of anticoagulants or antiplatelet agents with your doctor to evaluate bleeding risks.

Emergency Warning Signs

If you experience any of the following, seek immediate medical attention (go to the emergency department or call 911):

• Heavy bleeding that soaks a pad in under an hour or requires changing pads every hour.
• Signs of severe anemia: rapid heartbeat, shortness of breath at rest, fainting, or extreme fatigue.
• Severe pelvic or abdominal pain that rapidly worsens.
• Fever > 100.4 °F (38 °C) with bleeding – could indicate infection.
• Sudden onset of bleeding after a fall or trauma to the abdomen.

Key Takeaway

Postmenopausal bleeding is a signal that something in the reproductive tract needs attention. Prompt evaluation—typically starting with a transvaginal ultrasound and possibly an endometrial biopsy—allows clinicians to differentiate benign causes from serious conditions like cancer. Most women with PMB have a treatable cause, and early therapy dramatically improves outcomes.

---

References:

1. Mayo Clinic. “Postmenopausal bleeding.” https://www.mayoclinic.org
2. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 149: Endometrial Hyperplasia. 2023.
3. National Cancer Institute. “Uterine (Endometrial) Cancer Treatment (PDQ®)–Patient Version.” Updated 2024.
4. Cleveland Clinic. “Abnormal Uterine Bleeding After Menopause.” https://my.clevelandclinic.org
5. World Health Organization. “Menopause: Clinical Management and Guidelines.” 2022.

```